Dulaglutide and insulin microsecretion in people with type 1 diabetes (DIAMOND-GLP-1): A randomized double-blind placebo-controlled trial

Affiliations

• ¹ Centre du diabète DIAB-eCARE, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon France. Electronic address: [email protected].
• ² Department of Diabetology, Cochin Hospital AP-HP, University of Paris, Paris, France.
• ³ Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes F-44000, France.
• ⁴ Department of Endocrinology, Diabetes and Nutrition, Montpellier University Hospital, University of Montpellier, Montpellier, France.
• ⁵ Department of Diabetology, Metabolic diseases and Nutrition, CHU Toulouse, University of Toulouse, Toulouse, France.
• ⁶ Department of Endocrinology, Grenoble University Hospital, Grenoble Alpes University, INSERM U1055, LBFA, Grenoble, France.
• ⁷ Department of Endocrinology, Diabetology and Nutrition, CHRU of Nancy, Brabois Hospital, and ILCV Lorraine University, Vandoeuvre-les-Nancy, France.
• ⁸ Department of Clinical Research, pole IMER Hospices Civils de Lyon, Lyon, France.
• ⁹ Department of biochemistry and molecular biology, Lyon-Sud Hospital, Hospices Civils de Lyon, Lyon, France, Université Claude-Bernard Lyon 1, Oullins, France.